Mirae Asset Global ETFs Holdings
HUMA icon

Mirae Asset Global ETFs Holdings’s Humacyte HUMA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-73,878
Closed -$44.8K – 3241
2026
Q1 		$44.8K Buy
73,878
+1,856
+3% +$1.93K ﹤0.01% 2928
2025
Q4 		$69.2K Buy
72,022
+13,161
+22% +$18.6K ﹤0.01% 2833
2025
Q3 		$102K Sell
58,861
-18,114
-24% -$35.5K ﹤0.01% 2646
2025
Q2 		$161K Buy
76,975
+15,649
+26% +$30.1K ﹤0.01% 2386
2025
Q1 		$107K Buy
61,326
+1,877
+3% +$7.05K ﹤0.01% 2604
2024
Q4 		$301K Buy
59,449
+1,492
+3% +$7.38K ﹤0.01% 2172
2024
Q3 		$317K Buy
57,957
+23,117
+66% +$152K ﹤0.01% 2137
2024
Q2 		$167K Buy
+34,840
New +$181K ﹤0.01% 2347

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's HUMA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 73,878 shares — an estimated $44.8K sold.

Mirae Asset Global ETFs Holdings first reported a position in HUMA in Q2 2024 and held it in 8 quarters. The position peaked at $317K in Q3 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 73,878 Humacyte shares in Q2 2026, an estimated $44.8K.
  • Mirae Asset Global ETFs Holdings first reported a position in Humacyte in Q2 2024 and held it in 8 quarters.
  • Mirae Asset Global ETFs Holdings's Humacyte position peaked at $317K in Q3 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.